期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF IMMUNOTHERAPY LetPub Score 7.3
50 ratings
Rate
Reputation 8.8 Influence 6.2 Speed 7.0 | ||||||||||||||||||||||||||||
期刊簡稱 | J IMMUNOTHER | ||||||||||||||||||||||||||||
ISSN | 1524-9557 | ||||||||||||||||||||||||||||
E-ISSN | 1537-4513 | ||||||||||||||||||||||||||||
h-index | 89 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | http://journals.lww.com/immunotherapy-journal/pages/default.aspx | ||||||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/JIT | ||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||
出版商 | Lippincott Williams and Wilkins Ltd. | ||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||||||
創刊年 | 1997 | ||||||||||||||||||||||||||||
每年文章數 | 44每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 25.85% | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1524-9557%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Ordinary | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[JOURNAL OF IMMUNOTHERAPY] 的評論 | 撰寫評論 |
作者: 俊艾小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-25 18:43:07 評論於 Hello, do all authors need to click on that confirmation email for the manuscript?(0) 讚! | 俊艾小仙女 |
作者: 俊艾小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-25 18:14:28 評論於 Hello, do all authors need to click on the manuscript confirmation email?(0) 讚! | 俊艾小仙女 |
作者: 俊艾小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-25 17:31:28 評論於 Hello, do all authors need to click that confirmation email to verify the manuscript?(0) 讚! | 俊艾小仙女 |
作者: 俊艾小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-25 17:08:50 評論於 Hello, do all authors need to click on the manuscript confirmation email?(0) 讚! | 俊艾小仙女 |
作者: 俊艾小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-25 16:35:08 評論於 Hello, do all authors need to click on the manuscript confirmation email?(0) 讚! | 俊艾小仙女 |
作者: 俊艾小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-25 16:20:28 評論於 Hello, do all authors need to click on the manuscript confirmation email?(0) 讚! | 俊艾小仙女 |
作者: 俊艾小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-25 10:15:49 評論於 Hello, do all authors need to click on the manuscript confirmation email?(0) 讚! | 俊艾小仙女 |
作者: 俊艾小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-25 09:19:18 評論於 Hello, do all authors need to click on that confirmation email?(0) 讚! | 俊艾小仙女 |
作者: 俊艾小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-25 08:33:57 評論於 Hello, do all authors need to click on that confirmation email for the manuscript?(0) 讚! | 俊艾小仙女 |
作者: 晨风宵雨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-01 16:28:05 評論於 I have withdrawn the manuscript(0) 讚! | 晨风宵雨 |
作者: 晨风宵雨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-28 14:55:16 評論於 No response... considering whether to withdraw the submission. It's never been this slow before, frustrating(0) 讚! | 晨风宵雨 |
作者: 晨风宵雨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-28 11:32:24 評論於 It's been half a year and I've reminded them twice, but I'm not sure if I should withdraw the submission(0) 讚! | 晨风宵雨 |
作者: 云来淑惠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-24 23:51:13 評論於 I have also reminded multiple times(0) 讚! | 云来淑惠 |
作者: 猫巷少女睿慈 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-11 20:18:19 評論於 I've been under review for five months now. I've never seen a journal this slow. I've followed up once but received no response. Just followed up again. How is your submission doing?(0) 讚! | 猫巷少女睿慈 |
作者: 猫巷少女睿慈 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-10 23:41:22 評論於 This is the slowest journal I have ever seen in terms of review speed, and they don't even reply to reminders. At one point, I even suspected that I submitted to the wrong unknown journal. Please do not submit to this one(0) 讚! | 猫巷少女睿慈 |
作者: Novia Tom 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-01 19:34:29 評論於 It has been a month since submission, and it has always been marked as "received by editor." Does this mean it hasn't been sent for external review yet?(0) 讚! | Novia Tom |
作者: 晨风宵雨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-22 16:36:59 評論於 Review speed: 6.0 | Submission hit rate: 50.0 Experience sharing: Submitted on January 9th, still under review today (June 28th), reminded twice with no response. It will be even funnier if it gets rejected(0) 讚! | 晨风宵雨 |
作者: 晨风宵雨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-17 22:44:17 評論於 Have you sent it for external audit?(0) 讚! | 晨风宵雨 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:14:47 評論於 Post hoc comparison refers to setting additional groups based on the characteristics of the data after data collection is completed, proposing research hypotheses, and conducting statistical analyses; it is the testing of non-research hypotheses and further exploratory analysis of the results(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 21:08:33 評論於 SPSS (Statistical Product and Service Solutions), "Statistical Product and Service Solutions"(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 龙鳞孝礼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 17:57:58 評論於 What is post-hoc testing?(0) 讚! | 龙鳞孝礼 |
作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 14:59:31 評論於 What statistical methods are generally used in typical situations?(0) 讚! | 破戒阳平 |
作者: 雨巷少年意映 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-27 16:14:41 評論於 Review Speed: 1.0 Experience Sharing: On April 20, submitted a case series online, received an email the next day stating it did not meet the requirements of a case report with 2000 words and 10 references. Asked to revise and resubmit, clarified in email communication that it was a case series, not an individual case. Response indicated it could be resubmitted. Submitted on 4.22, rejected on 4.28, feedback stated that the submission did not receive a high enough priority rating to warrant publication. Provided suggestion to transfer to Medicine, a journal under Wolters Kluwer Health with an impact factor of around 1.6-1.8. Likely due to low quality of the article, response was extremely fast, results communicated within a week. Sharing for reference for fellow researchers(0) 讚! | 雨巷少年意映 |
作者: 丹旋小郎君 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-04-08 09:49:02 評論於 Review Speed: 1.0 Experience Sharing: A clinical retrospective prognosis study of immune checkpoint inhibitors was submitted on March 27, 2020. Two days later it was under review, and the review was completed on April 7th. It was rejected on April 8th. Overall, the experience was not bad, as only one reviewer's comments were received, which seemed quite professional(0) 讚! | 丹旋小郎君 |
作者: 天际代春 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-01-10 22:46:25 評論於 Review Speed: 3.0 Experience Sharing: I submitted for three months and then got rejected. It's really frustrating. Be careful where you submit!(0) 讚! | 天际代春 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us